Fondens formål er at virke for anæstesiologiens videnskabelige udvikling i de nordiske lande, herunder at fremme samarbejdet mellem de nordiske anæstesilæger og at udgive tidsskriftet Acta Anaesthesiologica Scandinavica.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 2.4 mio. | 1.6 mio. | 15.6 mio. | 15 mio. | 0 | |
CVR: 19040089
Compared to 135 companies in Andre udgiveraktiviteter, undtagen udgivelse af software
Comparison is based on industry median values
The financial health of ACTA ANAESTHESIOLOGICA SCANDINAVICA FONDEN appears robust, with a notable increase in revenue and profit in 2024, reaching 2,351,812 DKK and 1,569,542 DKK, respectively. This marks a significant growth from 2023, where revenue was 2,128,683 DKK and profit was 1,366,095 DKK, indicating a positive trend after a challenging year in 2022. The company has maintained a strong equity position of 14,950,740 DKK, suggesting stability and resilience despite previous fluctuations in profitability. Overall, the organization is positioned well within its industry, demonstrating a recovery and growth trajectory that highlights its operational strengths.
AI-generated summary
Companies in the same industry and area
companydata.dk